Hydrogels derived from demineralized and decellularized bone extracellular matrix
暂无分享,去创建一个
W. Bowen | M. J. Sawkins | K. Shakesheff | S. Badylak | L. White | H. Markides | L. Sidney | F. Rose | K.M. Shakesheff | M.J. Sawkins | P. Dhadda | H. Markides | L.E. Sidney | A.J. Taylor | F.R.A.J. Rose | S.F. Badylak | L.J. White | W. Bowen | P. Dhadda | A. Taylor | Laura E. Sidney | Adam J. Taylor | Lisa J. White
[1] V. Mudera,et al. Close dependence of fibroblast proliferation on collagen scaffold matrix stiffness , 2009, Journal of tissue engineering and regenerative medicine.
[2] Stephen F Badylak,et al. Natural anti-galactose alpha1,3 galactose antibodies delay, but do not prevent the acceptance of extracellular matrix xenografts. , 2002, Transplant immunology.
[3] Donald O Freytes,et al. Preparation and rheological characterization of a gel form of the porcine urinary bladder matrix. , 2008, Biomaterials.
[4] Stephen F Badylak,et al. Extracellular matrix-derived products modulate endothelial and progenitor cell migration and proliferation in vitro and stimulate regenerative healing in vivo. , 2010, Matrix biology : journal of the International Society for Matrix Biology.
[5] Zhen W. Zhuang,et al. Tissue-Engineered Lungs for in Vivo Implantation , 2010, Science.
[6] Charalampos Dinopoulos. Re: The article "Dinopoulos H, Dimitriou R, Giannoudis PV. Bone graft substitutes: what are the options? Surgeon. 2012 Aug;10(4):230-9. , 2013, The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland.
[7] Li Zhang,et al. Degradation products of extracellular matrix affect cell migration and proliferation. , 2009, Tissue engineering. Part A.
[8] M. Murray,et al. Decellularization of bovine anterior cruciate ligament tissues minimizes immunogenic reactions to alpha-gal epitopes by human peripheral blood mononuclear cells. , 2012, The Knee.
[9] U. Galili. The α‐gal epitope and the anti‐Gal antibody in xenotransplantation and in cancer immunotherapy , 2005 .
[10] S. Badylak,et al. Chemoattraction of progenitor cells by remodeling extracellular matrix scaffolds. , 2009, Tissue engineering. Part A.
[11] George P McCabe,et al. Extracellular matrix bioscaffolds for orthopaedic applications. A comparative histologic study. , 2006, The Journal of bone and joint surgery. American volume.
[12] Jean A. Niles,et al. Influence of acellular natural lung matrix on murine embryonic stem cell differentiation and tissue formation. , 2010, Tissue engineering. Part A.
[13] Min Yang,et al. Favorable effects of the detergent and enzyme extraction method for preparing decellularized bovine pericardium scaffold for tissue engineered heart valves. , 2009, Journal of biomedical materials research. Part B, Applied biomaterials.
[14] J. F. Woessner,et al. The determination of hydroxyproline in tissue and protein samples containing small proportions of this imino acid. , 1961, Archives of biochemistry and biophysics.
[15] L. Kaufman,et al. Rheology and confocal reflectance microscopy as probes of mechanical properties and structure during collagen and collagen/hyaluronan self-assembly. , 2009, Biophysical journal.
[16] J. Kearney,et al. An evaluation of the capacity of differently prepared demineralised bone matrices (DBM) and toxic residuals of ethylene oxide (EtOx) to provoke an inflammatory response in vitro. , 2001, Biomaterials.
[17] Donald O Freytes,et al. Esophageal reconstruction with ECM and muscle tissue in a dog model. , 2005, The Journal of surgical research.
[18] Kerry A. Daly,et al. Biologic scaffold composed of skeletal muscle extracellular matrix. , 2012, Biomaterials.
[19] G. C. Wood,et al. The formation of fibrils from collagen solutions. 1. The effect of experimental conditions: kinetic and electron-microscope studies. , 1960, The Biochemical journal.
[20] Alexander Huber,et al. The effects of processing methods upon mechanical and biologic properties of porcine dermal extracellular matrix scaffolds. , 2010, Biomaterials.
[21] J. Hollinger,et al. Commercially Available Demineralized Bone Matrix Compositions to Regenerate Calvarial Critical-Sized Bone Defects , 2006, Plastic and reconstructive surgery.
[22] George P McCabe,et al. Maintenance of human hepatocyte function in vitro by liver-derived extracellular matrix gels. , 2010, Tissue engineering. Part A.
[23] S. Badylak,et al. The Use of Extracellular Matrix as an Inductive Scaffold for the Partial Replacement of Functional Myocardium , 2006, Cell transplantation.
[24] W. Paule,et al. Postmortem degradation of demineralized bone matrix osteoinductive potential. Effect of time and storage temperature. , 1991, Clinical orthopaedics and related research.
[25] Alexander Huber,et al. Mechanical properties and in vivo behavior of a biodegradable synthetic polymer microfiber-extracellular matrix hydrogel biohybrid scaffold. , 2011, Biomaterials.
[26] Kerry A. Daly,et al. Effect of the alphaGal epitope on the response to small intestinal submucosa extracellular matrix in a nonhuman primate model. , 2009, Tissue engineering. Part A.
[27] Robert E Guldberg,et al. Spatiotemporal Delivery Strategies for Promoting Musculoskeletal Tissue Regeneration , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[28] P. Giannoudis,et al. Bone graft substitutes: What are the options? , 2012, The surgeon : journal of the Royal Colleges of Surgeons of Edinburgh and Ireland.
[29] Jay R. Lieberman,et al. A comparison of commercially available demineralized bone matrix for spinal fusion , 2007, European Spine Journal.
[30] Stephen F Badylak,et al. Quantification of DNA in biologic scaffold materials. , 2009, The Journal of surgical research.
[31] D. Hu,et al. Injectable skeletal muscle matrix hydrogel promotes neovascularization and muscle cell infiltration in a hindlimb ischemia model. , 2012, European cells & materials.
[32] George P McCabe,et al. Macrophage phenotype and remodeling outcomes in response to biologic scaffolds with and without a cellular component. , 2009, Biomaterials.
[33] Stephen F Badylak,et al. The extracellular matrix as a biologic scaffold material. , 2007, Biomaterials.
[34] J. P. Robinson,et al. Time-lapse confocal reflection microscopy of collagen fibrillogenesis and extracellular matrix assembly in vitro. , 2000, Biopolymers.
[35] D. Chitturi,et al. BMP depletion occurs during prolonged acid demineralization of bone: characterization and implications for graft preparation , 2011, Cell and Tissue Banking.
[36] Cato T. Laurencin,et al. Bone-Graft Substitutes: Facts, Fictions, and Applications , 2001, The Journal of bone and joint surgery. American volume.
[37] C. T. Wagner,et al. Evaluation criteria for musculoskeletal and craniofacial tissue engineering constructs: a conference report. , 2008, Tissue engineering. Part A.
[38] Stephen F Badylak,et al. Immune response to biologic scaffold materials. , 2008, Seminars in Immunology.
[39] K J Halbhuber,et al. Impact of decellularization of xenogeneic tissue on extracellular matrix integrity for tissue engineering of heart valves. , 2003, Journal of structural biology.
[40] N. Turner,et al. Functional skeletal muscle formation with a biologic scaffold. , 2010, Biomaterials.
[41] G. C. Wood. The formation of fibrils from collagen solutions. 2. A mechanism of collagen-fibril formation. , 1960, The Biochemical journal.
[42] D. Weber,et al. Xenogeneic extracellular matrix as an inductive scaffold for regeneration of a functioning musculotendinous junction. , 2010, Tissue engineering. Part A.
[43] K. Koval,et al. Bone grafts and bone graft substitutes in orthopaedic trauma surgery. A critical analysis. , 2007, The Journal of bone and joint surgery. American volume.
[44] Stephen F Badylak,et al. The extracellular matrix as a scaffold for tissue reconstruction. , 2002, Seminars in cell & developmental biology.
[45] J. Hollinger,et al. Demineralized bone matrix in bone repair: History and use☆ , 2012, Advanced Drug Delivery Reviews.
[46] Stephen F Badylak,et al. An overview of tissue and whole organ decellularization processes. , 2011, Biomaterials.
[47] A. Woolf,et al. Burden of major musculoskeletal conditions. , 2003, Bulletin of the World Health Organization.
[48] Jay R Lieberman,et al. Osteoinductivity of commercially available demineralized bone matrix. Preparations in a spine fusion model. , 2004, The Journal of bone and joint surgery. American volume.
[49] D. Markel,et al. Characterization of the inflammatory response to four commercial bone graft substitutes using a murine biocompatibility model , 2012, Journal of inflammation research.
[50] A. Panitch,et al. Influence of chondroitin sulfate on collagen gel structure and mechanical properties at physiologically relevant levels. , 2008, Biopolymers.
[51] M. Bostrom,et al. An Unexpected Outcome During Testing of Commercially Available Demineralized Bone Graft Materials: How Safe Are the Nonallograft Components? , 2001, Spine.
[52] M. Pozzi,et al. Preliminary experience in the use of an extracellular matrix to repair congenital heart diseases. , 2011, Interactive cardiovascular and thoracic surgery.
[53] Christopher A. Carruthers,et al. A hydrogel derived from decellularized dermal extracellular matrix. , 2012, Biomaterials.
[54] Hiroshi Yagi,et al. Organ reengineering through development of a transplantable recellularized liver graft using decellularized liver matrix , 2010, Nature Medicine.
[55] Ricardo Londono,et al. Consequences of ineffective decellularization of biologic scaffolds on the host response. , 2012, Biomaterials.